# Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea

> **NCT04499495** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 11385 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **OTHER:** PENTASA (mesalamine/ 5-Aminosalicylic acid (5-ASA)

## Key facts

- **NCT ID:** NCT04499495
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 11385 (ACTUAL)
- **Last updated:** 2022-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04499495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04499495, "Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04499495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*